What sector does BridgeBio Oncology Therapeutics, Inc. (BBOT) operate in?
BridgeBio Oncology Therapeutics, Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is BridgeBio Oncology Therapeutics, Inc. (BBOT) current stock price?
As of the latest data, BridgeBio Oncology Therapeutics, Inc. stock price is $8.86, with a previous close of $9.13. BridgeBio Oncology Therapeutics, Inc. lost -$0.27 in the last trading session, representing a -2.96% loss.
What is BridgeBio Oncology Therapeutics, Inc. (BBOT) current market capitalization?
BridgeBio Oncology Therapeutics, Inc. market cap is approximately 701.68 million.
What is BridgeBio Oncology Therapeutics, Inc. (BBOT) Earnings Per Share (EPS)?
The trailing EPS is -$1.11, and the forward EPS is -$2.05.
What is BridgeBio Oncology Therapeutics, Inc. (BBOT) EBITDA?
BridgeBio Oncology Therapeutics, Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -49.00 million.
Does BridgeBio Oncology Therapeutics, Inc. (BBOT) pay dividends?
No. BridgeBio Oncology Therapeutics, Inc. does not pay a dividend.
When is BridgeBio Oncology Therapeutics, Inc. (BBOT) next earnings report?
BridgeBio Oncology Therapeutics, Inc. is expected to release its next earnings report on December 31, 2025.
What is BridgeBio Oncology Therapeutics, Inc. (BBOT) beta (volatility) score?
BridgeBio Oncology Therapeutics, Inc. has a beta of 0.106, indicating lower volatility than the overall market.